Nisa Investment Advisors’s Jade Biosciences JBIO Stock Holding History

Nisa Investment Advisors’s Portfolio JBIO Stock Details JBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.6K	Buy	1,510 +139	+10%	+$2.9K	﹤0.01%	2014
2026 Q1	$19.3K	Buy	1,371 +900	+191%	+$13K	﹤0.01%	2028
2025 Q4	$7.27K	Buy	471 +428	+995%	+$5.02K	﹤0.01%	2354
2025 Q3	$371	Buy	+43	New	+$351	﹤0.01%	2889
2025 Q2	–	Sell	-25	Closed	-$2.18K	–	3040
2025 Q1	$2.18K	Hold	25	–	–	﹤0.01%	2449
2024 Q4	$2.3K	Buy	25 +19	+317%	+$1.64K	﹤0.01%	2447
2024 Q3	$418	Buy	6 +5	+500%	+$323	﹤0.01%	2751
2024 Q2	$37	Buy	+1	New	+$663	﹤0.01%	2913
2024 Q1	–	Hold	0	–	–	–	2637
2023 Q3	–	Hold	0	–	-$120	–	2778
2023 Q2	–	Hold	0	–	–	–	2759
2023 Q1	–	Hold	0	–	–	–	2530
2022 Q4	–	Hold	0	–	–	–	2580

Other funds holding JBIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nisa Investment Advisors's JBIO Position: Q2 2026 in Review

Nisa Investment Advisors increased its Jade Biosciences (JBIO) stake by 10% in Q2 2026, buying an estimated $2.9K and bringing the position to 1,510 shares worth $33.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2014.

Nisa Investment Advisors first reported a position in JBIO in Q2 2024 and has held it in 8 quarters since. 153 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

Nisa Investment Advisors held 1,510 shares of Jade Biosciences worth $33.6K as of Q2 2026.
Nisa Investment Advisors bought 139 Jade Biosciences shares in Q2 2026, an estimated $2.9K.
Jade Biosciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2014 holding.
Nisa Investment Advisors first reported a position in Jade Biosciences in Q2 2024 and has held it in 8 quarters since.
153 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.